Search Results

You are looking at 101 - 110 of 299 items for :

  • "Hyperthyroidism" x
Clear All
Jan Calissendorff Department of Clinical Science and Education, Section of Endocrinology, Karolinska Institutet, Södersjukhuset, Sweden

Search for other papers by Jan Calissendorff in
Google Scholar
PubMed
Close
,
Emil Mikulski Department of Medicine, Mälarsjukhuset, Eskilstuna, Sweden
Centre for Clinical Research in Sörmland, Uppsala University, Uppsala, Sweden

Search for other papers by Emil Mikulski in
Google Scholar
PubMed
Close
,
Erik H. Larsen National Food Institute, Technical University of Denmark, Søborg, Denmark

Search for other papers by Erik H. Larsen in
Google Scholar
PubMed
Close
, and
Marika Möller Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden
Centre for Clinical Research in Sörmland, Uppsala University, Uppsala, Sweden

Search for other papers by Marika Möller in
Google Scholar
PubMed
Close

all investigators [ 13 ]. As auto-antibodies did not change in these patients with autoimmune hyperthyroidism, Se does not appear to affect immunoglobulins in GD. Increased SePP concentration, in its capacity as a Se transporter protein, could

Free access
Camilla Bøgelund Larsen Department of Endocrinology, Odense University Hospital, Odense, Denmark
Department of Clinical Research, University of Southern Denmark, Odense, Denmark

Search for other papers by Camilla Bøgelund Larsen in
Google Scholar
PubMed
Close
,
Eva Rabing Brix Petersen Department of Clinical Biochemistry and Immunology, Hospital of Southern Jutland, Aabenraa, Denmark

Search for other papers by Eva Rabing Brix Petersen in
Google Scholar
PubMed
Close
,
Martin Overgaard Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark

Search for other papers by Martin Overgaard in
Google Scholar
PubMed
Close
, and
Steen Joop Bonnema Department of Endocrinology, Odense University Hospital, Odense, Denmark
Department of Clinical Research, University of Southern Denmark, Odense, Denmark

Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed
Close

the increased TSH had prompted a trial of levothyroxine (LT4) replacement therapy on the suspicion of thyroid failure. Up to 150 µg LT4 per day was given. Hereby, plasma TSH decreased to near-normal levels within a few weeks, but hyperthyroid symptoms

Free access
Gerd Krause Structural Biology, Leibniz-Forschungsinstitut für molekulare Pharmakologie (FMP), Berlin, Germany

Search for other papers by Gerd Krause in
Google Scholar
PubMed
Close
,
Anja Eckstein Department of Ophthalmology, University Hospital Essen, Essen, Germany

Search for other papers by Anja Eckstein in
Google Scholar
PubMed
Close
, and
Ralf Schülein Protein Trafficking, Leibniz-Forschungsinstitut für molekulare Pharmakologie (FMP), Berlin, Germany

Search for other papers by Ralf Schülein in
Google Scholar
PubMed
Close

]. Pathological activation of the TSHR by TSHR-stimulating autoimmune antibodies (TSAb) leads to the uncontrolled production of thyroid hormones T3 and T4 in the thyroid causing hyperthyroidism in Graves’ disease (GD) [ 5 ]. The TSAb binds to the TSHR at a similar

Free access
Roberto Negro Division of Endocrinology, ‘V. Fazzi' Hospital, Lecce

Search for other papers by Roberto Negro in
Google Scholar
PubMed
Close
,
Roberto Attanasio Endocrinology Service, Galeazzi Institute IRCCS, Milan

Search for other papers by Roberto Attanasio in
Google Scholar
PubMed
Close
,
Franco Grimaldi Endocrinology and Metabolic Disease Unit, Azienda Ospedaliero-Universitaria ‘S. Maria della Misericordia', Udine

Search for other papers by Franco Grimaldi in
Google Scholar
PubMed
Close
,
Claudio Marcocci Department of Clinical and Experimental Medicine, University of Pisa, Pisa

Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Close
,
Rinaldo Guglielmi Department of Endocrinology, Regina Apostolorum Hospital, Albano Laziale, Italy

Search for other papers by Rinaldo Guglielmi in
Google Scholar
PubMed
Close
, and
Enrico Papini Department of Endocrinology, Regina Apostolorum Hospital, Albano Laziale, Italy

Search for other papers by Enrico Papini in
Google Scholar
PubMed
Close

/day in 21% of cases, 100-200 µg/day in 60.2%, and >200 µg/day in 18.8% (p < 0.01). About half of the respondents would recommend Se supplementation for a patient in remission from hyperthyroidism for 18 months and with a clinical activity score of 2

Free access
Federica D’Aurizio Department of Laboratory Medicine, Institute of Clinical Pathology, University Hospital of Udine, Udine, Italy

Search for other papers by Federica D’Aurizio in
Google Scholar
PubMed
Close
,
Alessia Biasotto Department of Medicine, University of Udine, Udine, Italy

Search for other papers by Alessia Biasotto in
Google Scholar
PubMed
Close
,
Claudia Cipri Endocrinology, Metabolism and Clinical Nutrition Unit, University Hospital of Udine, Udine, Italy

Search for other papers by Claudia Cipri in
Google Scholar
PubMed
Close
,
Franco Grimaldi Endocrinology, Metabolism and Clinical Nutrition Unit, University Hospital of Udine, Udine, Italy

Search for other papers by Franco Grimaldi in
Google Scholar
PubMed
Close
,
Jessica Zucco Department of Laboratory Medicine, Institute of Clinical Pathology, University Hospital of Udine, Udine, Italy

Search for other papers by Jessica Zucco in
Google Scholar
PubMed
Close
,
Stefania Marzinotto Department of Laboratory Medicine, Institute of Clinical Pathology, University Hospital of Udine, Udine, Italy

Search for other papers by Stefania Marzinotto in
Google Scholar
PubMed
Close
,
Francesco Curcio Department of Laboratory Medicine, Institute of Clinical Pathology, University Hospital of Udine, Udine, Italy
Department of Medicine, University of Udine, Udine, Italy

Search for other papers by Francesco Curcio in
Google Scholar
PubMed
Close
, and
Salvatore Benvenga Department of Clinical and Experimental Medicine, Endocrinology Section, University of Messina, Messina, Italy

Search for other papers by Salvatore Benvenga in
Google Scholar
PubMed
Close

examination. Such symptoms, suggestive of hyperthyroidism/thyrotoxicosis, prompted a further evaluation of TFT. Although TSH continued to be normal, high levels of free thyroid hormones (FT4 = 39.7 pmol/L; FT3 = 15.2 pmol/L) were interpreted as evidence of

Open access
Sofie Larsen Rasmussen Department of Medical Endocrinology, Copenhagen University Hospital Rigshospitalet, Copenhagen

Search for other papers by Sofie Larsen Rasmussen in
Google Scholar
PubMed
Close
,
Lars Rejnmark Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Lars Rejnmark in
Google Scholar
PubMed
Close
,
Eva Ebbehøj Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Eva Ebbehøj in
Google Scholar
PubMed
Close
,
Ulla Feldt-Rasmussen Department of Medical Endocrinology, Copenhagen University Hospital Rigshospitalet, Copenhagen

Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Close
,
Åse Krogh Rasmussen Department of Medical Endocrinology, Copenhagen University Hospital Rigshospitalet, Copenhagen

Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Close
,
Jakob Bue Bjorner QualityMetric (an Optum Company), Lincoln, R.I., USA

Search for other papers by Jakob Bue Bjorner in
Google Scholar
PubMed
Close
, and
Torquil Watt Department of Medical Endocrinology, Copenhagen University Hospital Rigshospitalet, Copenhagen

Search for other papers by Torquil Watt in
Google Scholar
PubMed
Close

and the electronic version of the ThyPRO questionnaire [ 1 ]. Methods Study Population We included patients with a diagnosis of Graves' hyperthyroidism or autoimmune hypothyroidism who were in a clinically stable phase of their disease and

Free access
Joanna Bogusławska Centre of Postgraduate Medical Education, Department of Biochemistry and Molecular Biology, Warsaw, Poland

Search for other papers by Joanna Bogusławska in
Google Scholar
PubMed
Close
,
Marlena Godlewska Centre of Postgraduate Medical Education, Department of Biochemistry and Molecular Biology, Warsaw, Poland

Search for other papers by Marlena Godlewska in
Google Scholar
PubMed
Close
,
Ewa Gajda Centre of Postgraduate Medical Education, Department of Biochemistry and Molecular Biology, Warsaw, Poland

Search for other papers by Ewa Gajda in
Google Scholar
PubMed
Close
, and
Agnieszka Piekiełko-Witkowska Centre of Postgraduate Medical Education, Department of Biochemistry and Molecular Biology, Warsaw, Poland

Search for other papers by Agnieszka Piekiełko-Witkowska in
Google Scholar
PubMed
Close

hypothyroidism. In contrast, GD is mainly associated with hyperthyroidism, resulting from the presence of thyroid-stimulating antibodies which activate thyrotropin receptor (TSHR) on thyrocytes, leading to thyroid hyperplasia. Only a minor number of GD patients

Open access
Johannes W. Dietrich Department of Endocrinology and Diabetes, Medical Hospital I, Germany

Search for other papers by Johannes W. Dietrich in
Google Scholar
PubMed
Close
,
Patrick Müller Department of Cardiology and Angiology, Medical Hospital II, Germany
Heart Center Bad Neustadt, Clinic for Interventional Electrophysiology, Bad Neustadt an der Saale, Germany

Search for other papers by Patrick Müller in
Google Scholar
PubMed
Close
,
Fabian Schiedat Department of Cardiology and Angiology, Medical Hospital II, Germany

Search for other papers by Fabian Schiedat in
Google Scholar
PubMed
Close
,
Markus Schlömicher Department of Cardiac Surgery, Bergmannsheil University Hospitals, Ruhr University of Bochum, Bochum, Germany

Search for other papers by Markus Schlömicher in
Google Scholar
PubMed
Close
,
Justus Strauch Department of Cardiac Surgery, Bergmannsheil University Hospitals, Ruhr University of Bochum, Bochum, Germany

Search for other papers by Justus Strauch in
Google Scholar
PubMed
Close
,
Apostolos Chatzitomaris Department of Endocrinology and Diabetes, Medical Hospital I, Germany

Search for other papers by Apostolos Chatzitomaris in
Google Scholar
PubMed
Close
,
Harald H. Klein Department of Endocrinology and Diabetes, Medical Hospital I, Germany

Search for other papers by Harald H. Klein in
Google Scholar
PubMed
Close
,
Andreas Mügge Department of Cardiology and Angiology, Medical Hospital II, Germany

Search for other papers by Andreas Mügge in
Google Scholar
PubMed
Close
,
Josef Köhrle Institut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, Germany

Search for other papers by Josef Köhrle in
Google Scholar
PubMed
Close
,
Eddy Rijntjes Institut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, Germany

Search for other papers by Eddy Rijntjes in
Google Scholar
PubMed
Close
, and
Ina Lehmphul Institut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, Germany

Search for other papers by Ina Lehmphul in
Google Scholar
PubMed
Close

and atrial fibrillation (AF) are classical consequences of thyrotoxicosis included in two scoring systems for estimating the probability of thyroid storm [ 16 ]. Even subclinical hyperthyroidism is associated with increased risk for AF [ 17 ] and a

Free access
Susanne Neumann Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda, Bethesda, Maryland, USA

Search for other papers by Susanne Neumann in
Google Scholar
PubMed
Close
,
Christine C. Krieger Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda, Bethesda, Maryland, USA

Search for other papers by Christine C. Krieger in
Google Scholar
PubMed
Close
, and
Marvin C. Gershengorn Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda, Bethesda, Maryland, USA

Search for other papers by Marvin C. Gershengorn in
Google Scholar
PubMed
Close

Graves’ hyperthyroidism (GH) [ 9 ] and does not bind to IGF-1R [ 10 ], was inhibited by the IGF-1R antagonist linsitinib [ 6 ]; (3) stimulation by M22 and immunoglobulins purified from the sera of Graves’ disease (GD) patients with eye disease (GO

Free access
Heleen I Jansen Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands

Search for other papers by Heleen I Jansen in
Google Scholar
PubMed
Close
,
Antonius E van Herwaarden Radboud University Medical Center, Department of Laboratory Medicine, Nijmegen, The Netherlands

Search for other papers by Antonius E van Herwaarden in
Google Scholar
PubMed
Close
,
Henk J Huijgen Department of Clinical Chemistry, Red Cross Hospital, Beverwijk, The Netherlands

Search for other papers by Henk J Huijgen in
Google Scholar
PubMed
Close
,
Rebecca C Painter Department of Obstetrics and Gynaecology, Amsterdam UMC Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands

Search for other papers by Rebecca C Painter in
Google Scholar
PubMed
Close
,
Jacquelien J Hillebrand Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands

Search for other papers by Jacquelien J Hillebrand in
Google Scholar
PubMed
Close
,
Anita Boelen Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands

Search for other papers by Anita Boelen in
Google Scholar
PubMed
Close
, and
Annemieke C Heijboer Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands

Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Close

pregnancy, since the fetus does not produce thyroid hormone itself until 16–20 weeks ( 7 ). Untreated maternal hyperthyroidism can not only have fetal consequences such as intra-uterine growth restriction but also life-threatening maternal consequences as

Open access